Jan Zivny

Dr. Jan Zivny

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2008 in Proteomics
Verified
Journal Article
Open access
PDF file
JPJiří Petrák
Jiří Petrák
RIRobert Ivanek
Robert Ivanek
OTOndrej Toman
Ondrej Toman
RCRadek Cmejla
Radek Cmejla
Jana ČmejlováJana Čmejlová
Jana Čmejlová
CVChristopher D. Vulpe
Christopher D. Vulpe
After reading many 2‐DE‐based articles featuring lists of the differentially expressed proteins, one starts experiencing a disturbing déjà vu. The same proteins seem to predominate regardless of the experiment, tissue or species. To quantify the occurrence of individual differentially expressed proteins in 2‐DE experiment reports, we compiled the identities of differentially expressed proteins identified in human, mouse, and rat tissues published in three recent volumes of Proteomics and calculated the appearance of the most predominant proteins in the dataset. The most frequently identified protein is a highly abundant glycolytic enzyme enolase 1, differentially expressed in nearly every third experiment on both human and rodent tissues. Heat‐shock protein 27 (HSP27) and heat‐shock protein 60 (HSP60) were differentially expressed in about 30 percent of human and rodent samples, respectively. Considering protein families as units, keratins and peroxiredoxins are the most frequently identified molecules, with at least one member of the group being differentially expressed in about 40 percent of all experiments. We suggest that the frequent identification of these proteins must be considered in the interpretation of any 2‐DE studies. We consider if these commonly observed changes represent common cellular stress responses or are a reflection of the technical limitations of 2‐DE.

1 August 2009 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
MŽMartina Živná
Martina Živná
HHHelena Hůlková
Helena Hůlková
MMMarie Matignon
Marie Matignon
KHKateřina Hodaňová
Kateřina Hodaňová
PVPetr Vylet'AL
Petr Vylet'AL
SKStanislav Kmoch
Stanislav Kmoch

22 March 2003 in Biochemistry
Verified
Journal Article
Closed access
TWTobias Weber
Tobias Weber
HDHelge Dalen
Helge Dalen
LALadislav Andera
Ladislav Andera
Anne Negre-SalvayreAnne Negre-Salvayre
Anne Negre-Salvayre
NANathalie Augé
Nathalie Augé
JNJiri Neuzil
Jiri Neuzil

5 May 2004 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
JSJan Simak
Jan Simak
KHKarel Holada
Karel Holada
ARAntonio M. Risitano
Antonio M. Risitano
JZJan Zivny
Jan Zivny
NYNeal S. Young
Neal S. Young
JVJaroslav G. Vostal
Jaroslav G. Vostal
Summary: We analysed endothelial cell membrane microparticles (ECMP) in the peripheral blood of patients with paroxysmal nocturnal haemoglobinuria (PNH) (n = 9), aplastic anaemia (AA) (n = 10), sickle cell disease (SCD) (n = 8), and healthy donors (HD) (n = 11). There was no clinically manifested thrombosis in the PNH or AA group, except one cured thrombophlebitis (PNH), while all SCD patients had a history of vaso‐occlusive crises. We used three‐colour flow cytometry with blood cell‐specific antibodies and antibodies to endothelial antigens CD105 and CD144. Phosphatidylserine‐positive microparticles were detected using the annexin V‐binding (AVB) assay. The population of CD105+AVB+ ECMP was significantly (P < 0·05) higher in SCD (median: 0·568 × 109/l; 25–75th percentile range: 0·351–0·976 × 109/l) and PNH (0·401 × 109/l ; 0·19–0·441 × 109/l) patients when compared with AA (0·122 × 109/l; 0·061–0·172 × 109/l) or HD (0·180 × 109/l; 0·137–0·217 × 109/l) group. Even more pronounced differences were observed in ECMP exhibiting a marker of inflammatory stimulation CD54 (CD105+CD54+). Similarly, ECMP that exhibited endothelial specific and proteolysis‐sensitive antigen CD144 were increased in SCD and PNH, but not in AA. Elevated CD54+ ECMP may reflect the inflammatory status of endothelial cells in SCD and PNH, while CD144+ ECMP could indicate continuous endothelial stimulation and/or injury. Analysis of circulating ECMP appears promising to provide useful information on the status of the vascular endothelium in PNH and SCD.

1 May 1999 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
AKAnu Kantele
Anu Kantele
JZJan Zivny
Jan Zivny
MHMiikka HäkKinen
Miikka HäkKinen
CECharles O Elson
Charles O Elson
JMJiri Mestecky
Jiri Mestecky
Animal experiments show that lymphocytes activated in the intestine circulate through mesenteric lymph nodes, lymphatics, and blood, returning to the gut. Homing into intestinal lamina propria is mediated by lymphocyte surface homing receptors, mainly the α4β7-integrin. We studied in humans whether intestinal T cells entering the blood upon antigenic activation would exhibit homing commitments to the gut. Volunteers were immunized with keyhole limpet hemocyanin (KLH) first orally and then parenterally or only parenterally, and the expression of α4β7 on T cells specific for KLH or tetanus toxoid was studied. Circulating T cells were depleted of α4β7+ cells by immunomagnetic selection. This depletion removed a significant proportion of the KLH-specific cells (mean decrease in proliferative response of 71%) in the orally immunized volunteers. No difference in the KLH-induced proliferation was found between the total and the α4β7-depleted populations in volunteers parenterally immunized with KLH, regardless of whether a preceding mucosal priming had taken place or not. In both immunization groups, the depletion of α4β7+ cells had no influence on the proliferative response to tetanus toxoid. We conclude that, in contrast to T cells activated by parenteral immunization, gut-derived T cells have preferential homing commitments to the gut. This commitment was no longer observed after a subsequent parenteral Ag administration. Besides showing that the site of Ag encounter determines the expression of homing receptors, the present study is the first to provide evidence for a circulation of newly activated Ag-specific intestinal T cells back to the gut in humans.

1 September 2006 in Kidney International
Verified
Journal Article
Closed access
PVP. Vylet'AL
P. Vylet'AL
MKM. Kublová
M. Kublová
MKMarie Hubalek Kalbacova
Marie Hubalek Kalbacova
KHK. Hodaňová
K. Hodaňová
VBV. Barešová
V. Barešová
SKStanislav Kmoch
Stanislav Kmoch